DIAGMMR:

DIAGNOSTICS INNOVATION

Our Mission is to provide reliable Lynch syndrome diagnostics to empower families and healthcare professionals to make better informed decisions for cancer prevention.

Lynch Syndrome

LYNCH SYNDROME

1 in 279 people have Lynch syndrome, i.e. inherited mismatch repair (MMR) deficiency, making it the most common cause of hereditary cancers.

LS Drop

INHERITED DEFECT

Lynch syndrome (LS) is inherited with 50% probability within affected families. Each single year, more than 2 million new cancer cases should be tested for LS.

LS CancerDiag Microscope

INDIVIDUAL RISK

Individuals with inherited MMR deficiency have an up to 80% risk of developing cancer and at a significantly younger age than the general population.

DiagMMR Tube

INNOVATIVE SOLUTION

DiagMMR is a simple and accurate test to reliably detect MMR deficiency, supporting the early detection of Lynch syndrome, enabling preventive care and helping save lives.

We .

LS CancerDiag Logo

IS NOW

Lynsight

Click Here to Learn More

Invest today!

LS CancerDiag has launched a funding round in collaboration with Springvest

The company aims to raise €5.4M in capital to support the expansion into the United States and introduce DiagMMR® to the largest health care market in the world.